330 related articles for article (PubMed ID: 34168650)
1. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
Front Immunol; 2021; 12():681380. PubMed ID: 34168650
[TBL] [Abstract][Full Text] [Related]
2. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
Front Immunol; 2018; 9():991. PubMed ID: 29867968
[TBL] [Abstract][Full Text] [Related]
3. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
Slavuljica I; Busche A; Babić M; Mitrović M; Gašparović I; Cekinović D; Markova Car E; Pernjak Pugel E; Ciković A; Lisnić VJ; Britt WJ; Koszinowski U; Messerle M; Krmpotić A; Jonjić S
J Clin Invest; 2010 Dec; 120(12):4532-45. PubMed ID: 21099111
[TBL] [Abstract][Full Text] [Related]
4. Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ.
Trsan T; Busche A; Abram M; Wensveen FM; Lemmermann NA; Arapovic M; Babic M; Tomic A; Golemac M; Brinkmann MM; Jäger W; Oxenius A; Polic B; Krmpotic A; Messerle M; Jonjic S
Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16550-5. PubMed ID: 24052528
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8
Tršan T; Vuković K; Filipović P; Brizić AL; Lemmermann NAW; Schober K; Busch DH; Britt WJ; Messerle M; Krmpotić A; Jonjić S
Eur J Immunol; 2017 Aug; 47(8):1354-1367. PubMed ID: 28612942
[TBL] [Abstract][Full Text] [Related]
6. An attenuated temperature-sensitive strain of cytomegalovirus (tsm5) establishes immunity without development of CD8(+) T cell memory inflation.
Beswick M; Pachnio A; Al-Ali A; Sweet C; Moss PA
J Med Virol; 2013 Nov; 85(11):1968-74. PubMed ID: 23852921
[TBL] [Abstract][Full Text] [Related]
7. KLRG1+NKG2A+ CD8 T cells mediate protection and participate in memory responses during γ-herpesvirus infection.
Cush SS; Flaño E
J Immunol; 2011 Apr; 186(7):4051-8. PubMed ID: 21346231
[TBL] [Abstract][Full Text] [Related]
8. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
9. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
10. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
Ye M; Morello CS; Spector DH
J Virol; 2002 Mar; 76(5):2100-12. PubMed ID: 11836387
[TBL] [Abstract][Full Text] [Related]
11. Memory Inflation Drives Tissue-Resident Memory CD8
Morabito KM; Ruckwardt TJ; Bar-Haim E; Nair D; Moin SM; Redwood AJ; Price DA; Graham BS
Front Immunol; 2018; 9():1861. PubMed ID: 30154789
[TBL] [Abstract][Full Text] [Related]
12. Viral inoculum dose impacts memory T-cell inflation.
Redeker A; Welten SP; Arens R
Eur J Immunol; 2014 Apr; 44(4):1046-57. PubMed ID: 24356925
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
Front Immunol; 2021; 12():694588. PubMed ID: 34489940
[TBL] [Abstract][Full Text] [Related]
14. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57.
Ibegbu CC; Xu YX; Harris W; Maggio D; Miller JD; Kourtis AP
J Immunol; 2005 May; 174(10):6088-94. PubMed ID: 15879103
[TBL] [Abstract][Full Text] [Related]
15. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
Munks MW; Pinto AK; Doom CM; Hill AB
J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
[TBL] [Abstract][Full Text] [Related]
16. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
Ye M; Morello CS; Spector DH
J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
[TBL] [Abstract][Full Text] [Related]
17. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
18. The murine cytomegalovirus immunoevasin gp40/m152 inhibits NKG2D receptor RAE-1γ by intracellular retention and cell surface masking.
Lis N; Hein Z; Ghanwat SS; Ramnarayan VR; Chambers BJ; Springer S
J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34085696
[TBL] [Abstract][Full Text] [Related]
19. A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer.
Klyushnenkova EN; Kouiavskaia DV; Parkins CJ; Caposio P; Botto S; Alexander RB; Jarvis MA
J Immunother; 2012 Jun; 35(5):390-9. PubMed ID: 22576344
[TBL] [Abstract][Full Text] [Related]
20. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
Morello CS; Ye M; Spector DH
J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
